Nightingale Pharmaceuticals
National City, US · Founded 2015 · California corporation
Founders & leadership
T(
TALAL (BRIAN) SHEENAExecutive
DC
DAVID CHURCHExecutive
LA
LORENS ATTISHAExecutive
CM
CAROL MCBRIDEExecutive
MA
MELWYN ABREOExecutive
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 round · 2015
▶$1.7MraisedMar 2016 · 19 investors · PharmaceuticalsRule 506(b)
▶$1.7MraisedMar 2016 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- TALAL (BRIAN) SHEENAExecutive Officer, Director
- DAVID CHURCHExecutive Officer, Director
- LORENS ATTISHAExecutive Officer, Director
- CAROL MCBRIDEExecutive Officer, Director
- MELWYN ABREOExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.7M
- Minimum investment
- $10K
- Proceeds to insiders
- $220K
- First sale
- Feb 2015
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nightingale Pharmaceuticals raised?
- Nightingale Pharmaceuticals has disclosed $1.7M raised across 1 round.
- Where is Nightingale Pharmaceuticals headquartered?
- Nightingale Pharmaceuticals is headquartered in National City, US.